🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: A. Primary objective: 1 To assess the feasibility and the eff...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-09-12
Trial ID
NCT00866749
H. Lee Moffitt Cancer Center and Research Institute will be the Sunshine Pr...
Status
Completed
Location
Holtz Children's Hospital University of Miami Miller School of Medicine
Start Date
2011-07-18
Trial ID
NCT01324180
Treatments Being Tested
This study is a multicenter, single-arm, open-label Phase II exploratory cl...
Status
Recruiting
Location
Breast surgery department
Start Date
2026-01-07
Trial ID
NCT07380646
Treatments Being Tested
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
An experimental drug called EZN-3042 targets survivin, a protein expressed ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2010-08-24
Trial ID
NCT01186328
Treatments Being Tested
This is a phase I study using the Erwinia form of asparaginase in place of ...
Status
Terminated
Location
Childrens Hospital Los Angeles
Start Date
2009-04-13
Trial ID
NCT00928200
Pegylated-asparaginase (PEG-ASP) is an important part of the treatment of c...
Status
Completed
Location
Aahus University hospial, hematological department
Start Date
2017-08-23
Trial ID
NCT03267030
Treatments Being Tested
This phase II trial tests how well etoposide, prednisone, vincristine, cycl...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-05-08
Trial ID
NCT06738368
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
This is an open-label, single-arm pilot study of Oncaspar® with dexamethaso...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2013-07
Trial ID
NCT01878708
Treatments Being Tested